170 related articles for article (PubMed ID: 3971289)
1. Prognosis of level V malignant melanoma.
Bear HD; Neifeld JP; Kay S
Cancer; 1985 Mar; 55(6):1167-71. PubMed ID: 3971289
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
3. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).
Wanebo HJ; Woodruff J; Fortner JG
Cancer; 1975 Mar; 35(3):666-76. PubMed ID: 1111935
[TBL] [Abstract][Full Text] [Related]
5. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
6. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
7. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
8. Regional lymph node dissection for malignant melanoma of the extremities.
Roses DF; Harris MN; Gumport SL; Michelassi F; Coffey JA; Dubin N
Surgery; 1981 Jun; 89(6):654-9. PubMed ID: 7245026
[TBL] [Abstract][Full Text] [Related]
9. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study.
Gupta TK
Ann Surg; 1977 Aug; 186(2):201-9. PubMed ID: 889365
[TBL] [Abstract][Full Text] [Related]
10. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
[TBL] [Abstract][Full Text] [Related]
12. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Nathansohn N; Schachter J; Gutman H
Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
[TBL] [Abstract][Full Text] [Related]
13. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).
Wanebo HJ; Fortner JG; Woodruff J; MacLean B; Binkowski E
Ann Surg; 1975 Sep; 182(3):302-15. PubMed ID: 1164058
[TBL] [Abstract][Full Text] [Related]
14. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
15. A rational approach to the surgical management of melanoma.
Holmes EC; Moseley HS; Morton DL; Clark W; Robinson D; Urist MM
Ann Surg; 1977 Oct; 186(4):481-90. PubMed ID: 907393
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
17. Regional lymph node metastases and the level of invasion of primary melanoma.
Holmes EC; Clark W; Morton DL; Eilber FR; Bochow AJ
Cancer; 1976 Jan; 37(1):199-201. PubMed ID: 1247955
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
Kapelanski DP; Block GE; Kaufman M
Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
20. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]